Region (Main city) | n | Anti-HBc +ve | HBsAg +ve | IV drugs | Year | Reference |
---|---|---|---|---|---|---|
North (Belém) | 406 | 51.0% (46.0–56.0) | 7.9% (5.5–11.1) | 10.6% (7.9–14.1) | 2000 | 13 |
Central (Cuiabá) | 1,000 | 40.0% (37.0–43.1) | 3.7% (2.7–5.1) | 2.4% (1.6–3.6) | 2004 | Present study |
Southeast (Campinas) | 226 | 44.0% (37.5–50.7) | 5.3% (2.9–9.3) | 29.0% (23.3–35.5) | 1995 | 11 |
" (Ribeirão Preto) | 401 | 40.9% (36.1–45.9) | 8.5% (6.0–11.8) | 22.2% (18.3–26.6) | 2002 | 10 |
" (São Paulo) | 1,693 | 38.6% (36.3–41.0) | 5.7% (4.7–6.9) | - | 1996 | 12 |
South (Florianópolis) | 93 | 71.2% (60.7–79.9) | 24.3% (16.3–34.5) | 36.5% (26.9–47.2) | 1999 | 9 |